March 20, 2020
Telehealth Resources for Clinicians Providing MAT, Including OTPs
This is an announcement from the U.S. Centers for Medicare & Medicaid Services.
The U.S. Government is working tirelessly to minimize the spread of the coronavirus disease. The National Institute on Drug Abuse has noted that people with
Substance Use Disorders (SUDs) may be particularly vulnerable . We want to make sure providers, including Opioid Treatment Programs (OTPs), who treat patients with opioid use disorder (OUD) are aware of the options to use telehealth to prescribe medication for medication-assisted treatment (MAT) and other support services during the COVID-19 national health emergency:
Centers for Medicare &
Medicaid Services (CMS) expands telehealth benefits for Medicare and Medicaid patients
Drug Enforcement Agency (DEA)
guidance on issuing prescriptions for controlled substances during a public health emergency to patients for whom they have not conducted an in-person medical evaluation
Substance Abuse and Mental Health Services Administration (SAMHSA) guidance on potential flexibilities for take home medication, as well as
Frequently Asked Questions (FAQs)
View CMS’ FAQs on billing add-on codes for take-home medication and the threshold for billing the weekly bundled payment codes for additional assistance applying these flexibilities to Medicare claims
SAMHSA guidance on
medical emergency exceptions to 42 CFR Part 2 regulations on use and disclosure of patient identifying information for treatment purposes and to support elevated need for telehealth services
Office of Civil Rights (OCR) guidance on enforcement discretion for HIPAA Rules in connection with the use of telehealth
.png?cb=432961){kind=small}